Autologous hematopoietic stem cell transplantation in intermediate and high grade Non-Hodgkin's lymphoma: A review
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/4/suppl_1/S7/6678637/4-suppl_1-S7.pdf
Reference46 articles.
1. Dose: A critical factor in cancer chemotherapy;Frei;Am J Med,1980
2. Patterns of resistant and therapeutic synergism among alkylative agents;Schabel;Antibiot Chemother,1978
3. Alkylating agents: In vitro studies of cross-resistance patterns in human cell lines;Teicher;Cancer Res,1986
4. Gm–CSF instead of autologous bone marrow transplantation after the BEAM regimen;Laporte;The Lancet,1991
5. The role of dose intensity in determining outcome in intermediate grade non-Hodgkin’s lymphoma;Meyer;J Clin Oncol,1991
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Benefits of plerixafor for mobilization of peripheral blood stem cells prior to autologous transplantation: a dual-center retrospective cohort study;Cytotherapy;2023-07
2. Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma;Annals of Hematology;2016-05-11
3. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use;The Oncologist;2015-11-30
4. Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkin's Lymphoma;Clinical Lymphoma;2004-09
5. Mitoxantrone/Ifosfamide/Etoposide Salvage Regimen with Rituximab for In Vivo Purging in Patients with Relapsed Lymphoma;Clinical Lymphoma;2002-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3